Mast cell subsets and their functional modulation by the acanthocheilonema viteae product ES-62

Journal of Parasitology Research

Volumn 2013, Issue , 2013, Pages

  Ball, Dimity H ^a   Tay, Hwee Kee ^a   Bell, Kara S ^b   Coates, Michelle L ^b   Al Riyami, Lamyaa ^b   Rzepecka, Justyna ^b   Harnett, William ^b   Harnett, Margaret M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ES 62 PROTEIN; GLYCOPROTEIN; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE C ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACANTHOCHEILONEMA VITEAE; ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MAST CELL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CONNECTIVE TISSUE LIKE MAST CELL; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; IMMUNOMODULATION; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PERITONEAL DERIVED MAST CELL; PRIORITY JOURNAL;

EID: 84874595673     PISSN: 20900023     EISSN: 20900031     Source Type: Journal    
DOI: 10.1155/2013/961268     Document Type: Article

References (55)

1. Kinet J. P., The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annual Review of Immunology 1999 17 931 972 10.1146/annurev.immunol.17.1.931 (Pubitemid 29241144)
2. Kinet J. P., The essential role of mast cells in orchestrating inflammation. Immunological Reviews 2007 217 1 5 7 2-s2.0-34248141140 10.1111/j.1600-065X.2007.00528.x (Pubitemid 46718159)
3. Xu J. M., Shi G. P., Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocrine Reviews 2012 33 71 108 10.1210/er.2011-0013
4. Galli S. J., Tsai M., IgE and mast cells in allergic disease. Nature Medicine 2012 18 693 704 10.1038/nm.2755
5. Malbec O., Roget K., Schiffer C., Iannascoli B., Dumas A. R., Arock M., Daëron M., Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells. Journal of Immunology 2007 178 10 6465 6475 2-s2.0-34248219441 (Pubitemid 46717430)
6. Galli S. J., Grimbaldeston M., Tsai M., Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nature Reviews Immunology 2008 8 6 478 486 2-s2.0-44349101991 10.1038/nri2327 (Pubitemid 351733419)
7. Abraham S. N., John A. L. S., Mast cell-orchestrated immunity to pathogens. Nature Reviews Immunology 2010 10 6 440 452 2-s2.0-77952868792 10.1038/nri2782
8. Kalesnikoff J., Galli S. J., New developments in mast cell biology. Nature Immunology 2008 9 11 1215 1223 2-s2.0-54549103514 10.1038/ni.f.216
9. Ribatti D., Crivellato E., Chapter 4 the controversial role of mast cells in tumor growth. International Review of Cell and Molecular Biology 2009 275 89 131 2-s2.0-66149120295 10.1016/S1937-6448(09)75004-X
10. Gurish M. F., Boyce J. A., Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. Journal of Allergy and Clinical Immunology 2006 117 6 1285 1291 2-s2.0-33646911541 10.1016/j.jaci.2006.04.017 (Pubitemid 43810217)
11. Irani A. A., Schechter N. M., Craig S. S., Two types of human mast cells that have distinct neutral protease compositions. Proceedings of the National Academy of Sciences of the United States of America 1986 83 12 4464 4468 2-s2.0-0344778472 (Pubitemid 16057069)
12. Moon T. C., St Laurent C. D., Morris K. E., Marcet C., Yoshimura T., Sekar Y., Befus A. D., Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunology 2010 3 2 111 128 2-s2.0-77249134192 10.1038/mi.2009.136
13. Welle M., Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. Journal of Leukocyte Biology 1997 61 3 233 245 2-s2.0-0030977229 (Pubitemid 27149902)
14. Galli S. J., Borregaard N., Wynn T. A., Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nature Immunology 2011 12 11 1035 1044 2-s2.0-80054899779 10.1038/ni.2109
15. Irani A. M., Schwartz L. B., Human mast cell heterogeneity. Allergy Proceedings 1994 15 6 303 308 2-s2.0-0028558646
16. Crivellato E., Ribatti D., The fundamental contribution of William Bate Hardy to shape the concept of mast cell heterogeneity. British Journal of Haematology 2010 150 2 152 157 2-s2.0-77954336924 10.1111/j.1365-2141.2009. 07938.x
17. Kitamura Y., Heterogeneity of mast cells and phenotypic change between subpopulations. Annual Review of Immunology 1989 7 59 76 2-s2.0-0024348298 (Pubitemid 19138007)
18. Chen C. C., Grimbaldeston M. A., Tsai M., Weissman I. L., Galli S. J., Identification of mast cell progenitors in adult mice. Proceedings of the National Academy of Sciences of the United States of America 2005 102 32 11408 11413 2-s2.0-23844451378 10.1073/pnas.0504197102 (Pubitemid 41153833)
19. Franco C. B., Chen C. C., Drukker M., Weissman I. L., Galli S. J., Distinguishing mast cell and granulocyte differentiation at the single-cell level. Cell Stem Cell 2010 6 4 361 368 2-s2.0-77949895560 10.1016/j.stem.2010. 02.013
20. Rodewald H. R., Dessing M., Dvorak A. M., Galli S. J., Identification of a committed precursor for the mast cell lineage. Science 1996 271 5250 818 822 2-s2.0-0030024349 (Pubitemid 26058936)
21. Ogawa Y., Grant J. A., Mediators of anaphylaxis. Immunology and Allergy Clinics of North America 2007 27 2 249 260 2-s2.0-34248144060 10.1016/j.iac.2007.03.013 (Pubitemid 46705479)
22. Echtenacher B., Männel D. N., Hültner L., Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996 381 6577 75 77 2-s2.0-0029892080 10.1038/381075a0 (Pubitemid 26130005)
23. Malaviya R., Ikeda T., Ross E., Abraham S. N., Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF- α Nature 1996 381 6577 77 80 2-s2.0-0029981928 10.1038/381077a0 (Pubitemid 26130006)
24. Dawicki W., Marshall J. S., New and emerging roles for mast cells in host defence. Current Opinion in Immunology 2007 19 1 31 38 2-s2.0-33846086541 10.1016/j.coi.2006.11.006 (Pubitemid 46073696)
25. Gilfillan A. M., Beaven M. A., Regulation of mast cell responses in health and disease. Critical Reviews in Immunology 2011 31 6 475 530 2-s2.0-84859707412
26. Arock M., le Nours A., Malbec O., Daëron M., Ex vivo and in vitro primary mast cells. Methods in Molecular Biology 2008 415 241 254 2-s2.0-45549107022
27. Nagao K., Yokoro K., Aaronson S. A., Continuous lines of basophil/mast cells derived from normal mouse bone marrow. Science 1981 212 4492 333 335 2-s2.0-0019508893 (Pubitemid 11124823)
28. Metcalfe D. D., Mekori J. A., Rottem M., Mast cell ontogeny and apoptosis. Experimental Dermatology 1995 4 4 227 230 2-s2.0-0029082273 10.1111/j.1600-0625.1995.tb00250.x
29. Lantz C. S., Huff T. F., Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor. Journal of Immunology 1995 155 8 4024 4029 2-s2.0-0029125878
30. Karimi K., Redegeld F. A., Heijdra B., Nijkamp F. P., Stem cell factor and Interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Experimental Hematology 1999 27 4 654 662 2-s2.0-0032905425 10.1016/S0301-472X(98)00083-6 (Pubitemid 29181441)
31. Takano H., Nakazawa S., Okuno Y., Shirata N., Tsuchiya S., Kainoh T., Takamatsu S., Furuta K., Taketomi Y., Naito Y., Takematsu H., Kozutsumi Y., Tsujimoto G., Murakami M., Kudo I., Ichikawa A., Nakayama K., Sugimoto Y., Tanakag S., Establishment of the culture model system that reflects the process of terminal differentiation of connective tissue-type mast cells. FEBS Letters 2008 582 10 1444 1450 2-s2.0-42049085496 10.1016/j.febslet.2008.03.033
32. Tsuji K., Koike K., Komiyama A., Miyajima A., Arai K. I., Nakahata T., Synergistic action of interleukin-10 (IL-10) with IL-3, IL-4 and stem cell factor on colony formation from murine mast cells in culture. International Journal of Hematology 1995 61 2 51 60 2-s2.0-0028921675
33. Benoist C., Mathis D., Mast cells in autoimmune disease. Nature 2002 420 6917 875 878 2-s2.0-0037180783 10.1038/nature01324 (Pubitemid 36019641)
34. Bryce P. J., Miller M. L., Miyajima I., Tsai M., Galli S. J., Oettgen H. C., Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 2004 20 4 381 392 2-s2.0-1842684988 10.1016/S1074-7613(04) 00080-9 (Pubitemid 38482117)
35. Melendez A. J., Harnett M. M., Pushparaj P. N., Wong W. F., Tay H. K., McSharry C. P., Harnett W., Inhibition of Fc ε RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nature Medicine 2007 13 11 1375 1381 2-s2.0-35948948204 10.1038/nm1654 (Pubitemid 350073593)
36. Harnett W., Harnett M. M., Helminth-derived immunomodulators: Can understanding the worm produce the pill? Nature Reviews Immunology 2010 10 4 278 284 2-s2.0-77950083594 10.1038/nri2730
37. Pineda M. A., McGrath M. A., Smith P. C., The parasitic helminth product ES-62 suppresses pathogenesis in CIA by targeting of the IL-17-producing cellular network at multiple sites. Arthritis & Rheumatism 2012 64 10 3168 3178
38. Noguchi J., Kuroda E., Yamashita U., Strain difference of murine bone marrow-derived mast cell functions. Journal of Leukocyte Biology 2005 78 3 605 611 2-s2.0-24744459438 10.1189/jlb.1104676 (Pubitemid 41292082)
39. Goodridge H. S., Marshall F. A., Wilson E. H., Houston K. M., Liew F. Y., Harnett M. M., Harnett W., In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype. Immunology 2004 113 4 491 498 2-s2.0-9944234990 10.1111/j.1365-2567.2004.01993.x (Pubitemid 39593368)
40. Wu L. C., Immunoglobulin E receptor signaling and asthma. The Journal of Biological Chemistry 2011 286 32891 32897 10.1074/jbc.R110.205104
41. Li G., Lucas J. J., Gelfand E. W., Protein kinase C α β I, and β II isozymes regulate cytokine production in mast cells through MEKK2/ERK5-dependent and -independent pathways. Cellular Immunology 2005 238 1 10 18 2-s2.0-33344478256 10.1016/j.cellimm.2005.12.001 (Pubitemid 43288028)
42. Abdel-Raheem I. T., Hide I., Yanase Y., Shigemoto-Mogami Y., Sakai N., Shirai Y., Saito N., Hamada F. M., El-Mahdy N. A., Elsisy A. E. D. E., Sokar S. S., Nakata Y., Protein kinase C- α mediates TNF release process in RBL-2H3 mast cells. British Journal of Pharmacology 2005 145 4 415 423 2-s2.0-22044433042 10.1038/sj.bjp.0706207 (Pubitemid 40966270)
43. 2+ channels: implications for lipopolysaccharide exacerbating allergic asthma. Experimental Physiology 2012 97 12 1315 1327 2-s2.0-84862252793 10.1113/expphysiol.2012.065854
44. Nigo Y. I., Yamashita M., Hirahara K., Shinnakasu R., Inami M., Kimura M., Hasegawa A., Kohno Y., Nakayama T., Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2286 2291 2-s2.0-33144468160 10.1073/pnas.0510685103 (Pubitemid 43271662)
45. Loegering D. J., Lennartz M. R., Protein kinase C and toll-like receptor signaling. Enzyme Research 2011 2011 7 537821 10.4061/2011/537821
46. Leontieva O. V., Black J. D., Identification of two distinct pathways of protein kinase C α down-regulation in intestinal epithelial cells. Journal of Biological Chemistry 2004 279 7 5788 5801 2-s2.0-1242339601 10.1074/jbc.M308375200 (Pubitemid 38220610)
47. Prevostel C., Alice V., Joubert D., Parker P. J., Protein kinase C α actively downregulates through caveolae-dependent traffic to an endosomal compartment. Journal of Cell Science 2000 113 part 14 2575 2584 2-s2.0-0033858056 (Pubitemid 30601379)
48. Deehan M. R., Harnett M. M., Harnett W., A filarial nematode secreted product differentially modulates expression and activation of protein kinase C isoforms in B lymphocytes. Journal of Immunology 1997 159 12 6105 6111 2-s2.0-0031573557 (Pubitemid 127471549)
49. Lee S., Sato Y., Nixon R. A., Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. Journal of Neuroscience 2011 31 21 7817 7830 2-s2.0-79957663035 10.1523/JNEUROSCI.6412-10.2011
50. Xiao K., Shenoy S. K., β 2-adrenergic receptor lysosomal trafficking is regulated by ubiquitination of lysyl residues in two distinct receptor domains. Journal of Biological Chemistry 2011 286 14 12785 12795 2-s2.0-79953296222 10.1074/jbc.M110.203091
51. Newton K., Dixit V. M., Signaling in innate immunity and inflammation. Cold Spring Harbor Laboratory Press. In press
52. Kim Y., Kim K., Lee H., Han S., Lee Y. S., Choe J., Kim Y. M., Hahn J. H., Ro J. Y., Jeoung D., Celastrol binds to ERK and inhibits Fc ε RI signaling to exert an anti-allergic effect. European Journal of Pharmacology 2009 612 1-3 131 142 2-s2.0-65549157628 10.1016/j.ejphar.2009.03.071
53. Kim Y., Lee Y. S., Hahn J. H., Choe J., Kwon H. J., Ro J. Y., Jeoung D., Hyaluronic acid targets CD44 and inhibits Fc ε RI signaling involving PKC δ Rac1, ROS, and MAPK to exert anti-allergic effect. Molecular Immunology 2008 45 9 2537 2547 2-s2.0-40849102303 10.1016/j.molimm.2008.01.008
54. O'Neill L. A. J., Bowie A. G., The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews Immunology 2007 7 5 353 364 2-s2.0-34247566510 10.1038/nri2079 (Pubitemid 46674493)
55. S. Keck, I. Müller, G. Fejer et al., "Absence of TRIF signaling in lipopolysaccharide-stimulated murine mast cells," Journal of Immunology, vol. 186, no. 9, pp. 5478-5488, 2011.